|
US2020262804A1
|
|
Isotopically-stabilized tetronimide compounds
|
|
WO2019246093A1
|
|
Monoclonal antibodies targeting epitopes of asph
|
|
EP3813942A1
|
|
Alterations in endothelin receptors following hemorrhage and resuscitation by centhaquin
|
|
AU2014256346A1
|
|
Novel therapeutic treatments using centhaquin
|
|
AU2014287427A1
|
|
Compositions and methods for treating neuropsychiatric disorders using an endothelin-B receptor agonist
|
|
BR112015004643A2
|
|
methods and compositions for hypotensive resuscitation
|
|
CN102548553A
|
|
Method and composition for treating diabetic ketoacidosis
|
|
CN103989682A
|
|
Novel therapeutic treatments using centhaquin
|
|
EP2182977A2
|
|
Compositions for the treatment of stroke or cerebrovascular accidents with an endothelin b receptor agonist
|
